title: Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.
abstract: Longitudinal blood collections from cohort studies provide the means to search for proteins associated with disease before clinical diagnosis. We investigated plasma samples from the Women's Health Initiative (WHI) cohort to determine quantitative differences in plasma proteins between subjects subsequently diagnosed with colorectal cancer (CRC) and matched controls that remained cancer-free during the period of follow-up. Proteomic analysis of WHI samples collected before diagnosis of CRC resulted in the identification of six proteins with significantly (P < 0.05) elevated concentrations in cases compared with controls. Proteomic analysis of two CRC cell lines showed that five of the six proteins were produced by cancer cells. Microtubule-associated protein RP/EB family member 1 (MAPRE1), insulin-like growth factor-binding protein 2 (IGFBP2), leucine-rich alpha-2-glycoprotein (LRG1), and carcinoembryonic antigen (CEA) were individually assayed by enzyme linked immunosorbent assay (ELISA) in 58 pairs of newly diagnosed CRC samples and controls and yielded significant elevations (P < 0.05) among cases relative to controls. A combination of these four markers resulted in a receiver operating characteristics curve with an area under the curve value of 0.841 and 57% sensitivity at 95% specificity. This combination rule was tested in an independent set of WHI samples collected within 7 months before diagnosis from cases and matched controls resulting in 41% sensitivity at 95% specificity. A panel consisting of CEA, MAPRE1, IGFBP2, and LRG1 has predictive value in prediagnostic CRC plasmas.
authors.affiliation: Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA. jladd@fhcrc.org
authors.forename: Jon J
authors.initials: JJ
authors.lastname: Ladd
authors.forename: Tina
authors.initials: T
authors.lastname: Busald
authors.forename: Melissa M
authors.initials: MM
authors.lastname: Johnson
authors.forename: Qing
authors.initials: Q
authors.lastname: Zhang
authors.forename: Sharon J
authors.initials: SJ
authors.lastname: Pitteri
authors.forename: Hong
authors.initials: H
authors.lastname: Wang
authors.forename: Dean E
authors.initials: DE
authors.lastname: Brenner
authors.forename: Paul D
authors.initials: PD
authors.lastname: Lampe
authors.forename: Raju
authors.initials: R
authors.lastname: Kucherlapati
authors.forename: Ziding
authors.initials: Z
authors.lastname: Feng
authors.forename: Ross L
authors.initials: RL
authors.lastname: Prentice
authors.forename: Samir M
authors.initials: SM
authors.lastname: Hanash
mesh_terms: D025601:Adenomatous Polyposis Coli Protein / Q000378:metabolism; D000368:Aged; D002272:Carcinoembryonic Antigen / Q000378:metabolism; D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms / Q000097:blood* / Q000175:diagnosis*; D004252:DNA Mutational Analysis / Q000379:methods; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000097:blood*; D013058:Mass Spectrometry / Q000379:methods; D008869:Microtubule-Associated Proteins / Q000097:blood*; D008875:Middle Aged; D010455:Peptides / Q000737:chemistry; D012372:ROC Curve; D012680:Sensitivity and Specificity
chemical_list: D025601:Adenomatous Polyposis Coli Protein; D002272:Carcinoembryonic Antigen; D006023:Glycoproteins; D018971:Insulin-Like Growth Factor Binding Protein 2; C015246:LRG1 protein, human; C500985:MAPRE1 protein, human; D008869:Microtubule-Associated Proteins; D010455:Peptides